Skip to main content
logo
Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · Real-Time Price · USD
21.73
+0.32 (1.49%)
At close: Nov 10, 2026, 4:00 PM EST
21.10
-0.63 (-2.90%)
After-hours: Nov 10, 2026, 7:59 PM EST

Structure Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Selling, General & Admin
80.861.5549.4132.6716.378.59
Research & Development
369.81225.26108.8170.136.1929.11
Other Operating Expenses
-100-100----
Operating Expenses
350.6186.81158.23102.7852.5637.7
Operating Income
-350.6-186.81-158.23-102.78-52.56-37.7
Interest Expense
------0.12
Interest & Investment Income
47.2435.8736.0113.391.26-
EBT Excluding Unusual Items
-303.36-150.94-122.22-89.38-51.3-37.82
Gain (Loss) on Sale of Assets
10.2510.25----
Pretax Income
-293.12-140.69-122.22-89.38-51.3-37.82
Income Tax Expense
0.770.520.310.240.020.23
Net Income
-293.88-141.2-122.53-89.62-51.32-38.05
Preferred Dividends & Other Adjustments
----1.525.72
Net Income to Common
-293.88-141.2-122.53-89.62-52.84-43.77
Net Income Growth
------
Shares Outstanding (Basic)
7059533733
Shares Outstanding (Diluted)
7059533733
Shares Change
21.95%12.46%43.31%1049.81%17.72%30.01%
EPS (Basic)
-4.18-2.39-2.33-2.44-16.54-16.13
EPS (Diluted)
-4.19-2.39-2.33-2.44-16.54-16.13
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-277.28-225.81-117.93-81.66-46.28-33.37
Free Cash Flow Per Share
-3.94-3.81-2.24-2.22-14.48-12.30
EBITDA
-348.69-185.13-157.23-102.46-52.28-37.62
D&A For EBITDA
1.911.6810.320.280.07
EBIT
-350.6-186.81-158.23-102.78-52.56-37.7
SEC Filings: 10-K · 10-Q